The Nasdaq Composite (^IXIC) opened Wednesday’s session on the back foot, slipping 0.21% as investors adopted a wait-and-see posture ahead of a day packed with market-moving catalysts. With the Federal Reserve set to deliver its latest rate decision this afternoon and four of the Big Tech companies reporting earnings after the bell, caution was the ... Nasdaq Composite Treads Carefully Ahead of Bi...
The Nasdaq Composite (^IXIC) opened Wednesday’s session on the back foot, slipping 0.21% as investors adopted a wait-and-see posture ahead of a day packed with market-moving catalysts. With the Federal Reserve set to deliver its latest rate decision this afternoon and four of the Big Tech companies reporting earnings after the bell, caution was the ... Nasdaq Composite Treads Carefully Ahead of Big Tech Bonanza, Fed Decision
Looking at the universe of stocks we cover at Dividend Channel, on 5/1/26, First Trust Senior Floating Rate Income Fund II (Symbol: FCT) will trade ex-dividend, for its monthly dividend of $0.097, payable on 5/15/26. As a percentage of FCT's recent stock price of $9.84, this di
Looking at the universe of stocks we cover at Dividend Channel, on 5/1/26, First Trust Senior Floating Rate Income Fund II (Symbol: FCT) will trade ex-dividend, for its monthly dividend of $0.097, payable on 5/15/26. As a percentage of FCT's recent stock price of $9.84, this di
Sign up now! Sign up now! Sign up now? Sign up now! While a match-up between Bayern Munich and Paris Saint-Germain would almost certainly be most neutrals’ Bigger Cup final of choice, the major benefit of these two European heavyweights meeting in the semi-finals is that we get to watch them do it all again next week. While Football Daily has occasionally felt first-world resentment at being force...
Sign up now! Sign up now! Sign up now? Sign up now! While a match-up between Bayern Munich and Paris Saint-Germain would almost certainly be most neutrals’ Bigger Cup final of choice, the major benefit of these two European heavyweights meeting in the semi-finals is that we get to watch them do it all again next week. While Football Daily has occasionally felt first-world resentment at being forced to sit through no end of turgid footballing dross masquerading as top-tier, top-flight entertainment this season, last night we felt genuinely sorry for any football fans who couldn’t enjoy the otherworldly treat served up in Paris . For many in the UK, the cost of watching Europe’s elite is an unaffordable luxury when they’re already struggling to put light in the bulb and food on the table. And while Pep Guardiola’s budget almost certainly stretches to an Amazon Prime subscription, last night the Manchester City boss took an ill-advised punt on Stockport County and Port Vale providing more bang for his buck at Edgeley Park. Looking at that photo of Messi from 2005 (yesterday’s Quote of the Day), I had no idea before seeing his T-shirt that he was so left wing. We all know he did his best work off the right” – Andy McGregor. A mention in Football Daily of Nike ‘Phantom Elite’ boots made me realise I may have missed some stages in the overdramatisation of product names in football. In my day we used to just call them Pumas, or Umbros or (quietly) Golas. Now it seems we’re just a few seasons away from kids clamouring for the new Nike Mega Eagle Missile Ghost Boss boots (as worn by Emil Krafth)” – Andrew Boulton. What an absurd, breathless, brilliant game that was between PSG and Bayern last night. It was so end to end that, every time the camera panned to either end of the ground, I was surprised to see the keeper stood in a proper football goal, rather than between two piles of jumpers. I was also fully expecting the match to be brought to an end by a teacher marching ont...
Looking at the universe of stocks we cover at Dividend Channel, on 5/1/26, Emera Inc (Symbol: EMA) will trade ex-dividend, for its quarterly dividend of $0.7325, payable on 5/15/26. As a percentage of EMA's recent stock price of $52.87, this dividend works out to approximately
Looking at the universe of stocks we cover at Dividend Channel, on 5/1/26, Emera Inc (Symbol: EMA) will trade ex-dividend, for its quarterly dividend of $0.7325, payable on 5/15/26. As a percentage of EMA's recent stock price of $52.87, this dividend works out to approximately
In the warm sun, gathering handfuls of hard olives promised a taste of home that residents of a village in the Homs countryside had been missing for nearly 14 years of civil war.
In the warm sun, gathering handfuls of hard olives promised a taste of home that residents of a village in the Homs countryside had been missing for nearly 14 years of civil war.
Timberland Bancorp ( TSBK ) declares $0.29/share quarterly dividend , in line with previous. Forward yield 2.82% Payable May 22; for shareholders of record May 8; ex-div May 8. See TSBK Dividend Scorecard, Yield Chart, & Dividend Growth. More on Timberland Bancorp Dividend scorecard for Timberland Bancorp Financial information for Timberland Bancorp
Timberland Bancorp ( TSBK ) declares $0.29/share quarterly dividend , in line with previous. Forward yield 2.82% Payable May 22; for shareholders of record May 8; ex-div May 8. See TSBK Dividend Scorecard, Yield Chart, & Dividend Growth. More on Timberland Bancorp Dividend scorecard for Timberland Bancorp Financial information for Timberland Bancorp
Wheat is trading at new highs early on Wednesday, with gains across the board. The wheat complex posted a double digit rally across the three exchanges on Tuesday. Chicago SRW futures were 17 to 28 1/4 cents higher on Tuesday. Open interest was down 1,644 contracts on Tuesday. KC HRW...
Wheat is trading at new highs early on Wednesday, with gains across the board. The wheat complex posted a double digit rally across the three exchanges on Tuesday. Chicago SRW futures were 17 to 28 1/4 cents higher on Tuesday. Open interest was down 1,644 contracts on Tuesday. KC HRW...
Live cattle futures posted Tuesday gains of $2.12 to $4.55. Open interest was up 8,650 contracts on Tuesday, suggesting new buying interest. Cash trade got kicked off early again this week, but on a higher, note at $252 live and 395-396 dressed in the north. Southern action was still quiet,...
Live cattle futures posted Tuesday gains of $2.12 to $4.55. Open interest was up 8,650 contracts on Tuesday, suggesting new buying interest. Cash trade got kicked off early again this week, but on a higher, note at $252 live and 395-396 dressed in the north. Southern action was still quiet,...
Soybeans are trading with 4 to 5 cent gains so far on Wednesday morning. Futures closed the Tuesday session with front months down 1 to 4 ¼ cents in the front months and fractionally to 1 ¼ cents higher in the deferreds. Preliminary open interest was down 38,061 contracts in...
Soybeans are trading with 4 to 5 cent gains so far on Wednesday morning. Futures closed the Tuesday session with front months down 1 to 4 ¼ cents in the front months and fractionally to 1 ¼ cents higher in the deferreds. Preliminary open interest was down 38,061 contracts in...
Lean hog futures closed the Tuesday session with contracts down 20 to 77 cents. Open interest was up 608 contracts. USDA’s national base hog price was reported at $92.56 on Tuesday afternoon, up $2.32 from the day prior. The CME Lean Hog Index was back down 18 cents on April...
Lean hog futures closed the Tuesday session with contracts down 20 to 77 cents. Open interest was up 608 contracts. USDA’s national base hog price was reported at $92.56 on Tuesday afternoon, up $2.32 from the day prior. The CME Lean Hog Index was back down 18 cents on April...
Looking at the universe of stocks we cover at Dividend Channel, on 4/30/26, Fuller Company (Symbol: FUL) will trade ex-dividend, for its quarterly dividend of $0.245, payable on 5/14/26. As a percentage of FUL's recent stock price of $61.84, this dividend works out to approxima
Looking at the universe of stocks we cover at Dividend Channel, on 4/30/26, Fuller Company (Symbol: FUL) will trade ex-dividend, for its quarterly dividend of $0.245, payable on 5/14/26. As a percentage of FUL's recent stock price of $61.84, this dividend works out to approxima
Looking at the universe of stocks we cover at Dividend Channel, on 5/1/26, Delek US Holdings Inc (Symbol: DK) will trade ex-dividend, for its quarterly dividend of $0.255, payable on 5/8/26. As a percentage of DK's recent stock price of $44.32, this dividend works out to approx
Looking at the universe of stocks we cover at Dividend Channel, on 5/1/26, Delek US Holdings Inc (Symbol: DK) will trade ex-dividend, for its quarterly dividend of $0.255, payable on 5/8/26. As a percentage of DK's recent stock price of $44.32, this dividend works out to approx
In this extract from a new book on Sheffield’s musical history, Monkeys drummer Matt Helders and the cream of the city’s indie scene look back on the febrile mid-00s – from brilliant tunes to ‘brainless violence’ In 2005, enough of a storm seemed to be brewing in northern British indie music that NME tried to coin a new genre to encompass it all: New Yorkshire. “Forget LA, New York or London,” the...
In this extract from a new book on Sheffield’s musical history, Monkeys drummer Matt Helders and the cream of the city’s indie scene look back on the febrile mid-00s – from brilliant tunes to ‘brainless violence’ In 2005, enough of a storm seemed to be brewing in northern British indie music that NME tried to coin a new genre to encompass it all: New Yorkshire. “Forget LA, New York or London,” the feature read. “New Yorkshire is the best new band scene in Britain.” The magazine lumped together a bunch of disparate bands such as Sheffield’s Arctic Monkeys, the Long Blondes, Milburn, Harrisons and Bromheads Jacket, along with a Leeds and Wakefield bunch comprised of Kaiser Chiefs, the Cribs, Black Wire, the Research, ¡Forward, Russia!, the Ivories and the Sunshine Underground. The New Yorkshire tag, though, had overlooked a fairly noticeable split in Sheffield at the time between the artier indie bands, often students, and the more traditional local indie outfits. Continue reading...
Justin Paget/DigitalVision via Getty Images Thesis Tesla ( TSLA ) stock is always in the hot seat for investors abroad, touting a lofty valuation and perhaps loftier ambitions. I haven't covered this stock in quite some time, but today I'm going to break down why I still struggle to get behind Tesla's current valuation, even though I do believe the company's energy generation and storage segment, ...
Justin Paget/DigitalVision via Getty Images Thesis Tesla ( TSLA ) stock is always in the hot seat for investors abroad, touting a lofty valuation and perhaps loftier ambitions. I haven't covered this stock in quite some time, but today I'm going to break down why I still struggle to get behind Tesla's current valuation, even though I do believe the company's energy generation and storage segment, Terafab, and Optimus ventures could be a massive success story down the road. Let's dive in. 1Q26 Earnings Tesla reported mixed 1Q26 earnings, with a miss on revenue and vehicle deliveries, and a beat on net income, earnings, and margin expansion. The revenue miss falls in line with my expectations, as the company's automotive performance has been cooling down and pricing headwinds for their energy generation and storage segment are likely to be setting in. While automotive sales were up 20% YoY, the annual trend has been on a downward trajectory. I'd like to see longer-term improvement in automotive sales before getting excited about those figures. Energy generation and storage were cited to have fallen due to a decrease in Megapack and Powerwall deployments. Make of this what you will, but I believe this is a result of a cost-to-entry barrier that I mentioned previously. This doesn't change my take on the energy generation and storage segment long-term, as I believe the transition to alternative energy will bode well for Tesla looking forward. As expected, automotive regulatory credits were down 36% YoY, which I continue to believe will be problematic for Tesla. Bullish investors may combat this ideology with the fact that earnings beat and margins expanded; however, it is noted in Tesla's 10-Q that these figures came in higher than expected partly due to one-off warranty and tariff benefits. Tesla's services and other figures are likely the highlight of the report, up 42% YoY. As Tesla continues to sell more vehicles, FSD sales, supercharging, maintenance, and insurance ...
Justin Paget/DigitalVision via Getty Images Thesis Tesla ( TSLA ) stock is always in the hot seat for investors abroad, touting a lofty valuation and perhaps loftier ambitions. I haven't covered this stock in quite some time, but today I'm going to break down why I still struggle to get behind Tesla's current valuation, even though I do believe the company's energy generation and storage segment, ...
Justin Paget/DigitalVision via Getty Images Thesis Tesla ( TSLA ) stock is always in the hot seat for investors abroad, touting a lofty valuation and perhaps loftier ambitions. I haven't covered this stock in quite some time, but today I'm going to break down why I still struggle to get behind Tesla's current valuation, even though I do believe the company's energy generation and storage segment, Terafab, and Optimus ventures could be a massive success story down the road. Let's dive in. 1Q26 Earnings Tesla reported mixed 1Q26 earnings, with a miss on revenue and vehicle deliveries, and a beat on net income, earnings, and margin expansion. The revenue miss falls in line with my expectations, as the company's automotive performance has been cooling down and pricing headwinds for their energy generation and storage segment are likely to be setting in. While automotive sales were up 20% YoY, the annual trend has been on a downward trajectory. I'd like to see longer-term improvement in automotive sales before getting excited about those figures. Energy generation and storage were cited to have fallen due to a decrease in Megapack and Powerwall deployments. Make of this what you will, but I believe this is a result of a cost-to-entry barrier that I mentioned previously. This doesn't change my take on the energy generation and storage segment long-term, as I believe the transition to alternative energy will bode well for Tesla looking forward. As expected, automotive regulatory credits were down 36% YoY, which I continue to believe will be problematic for Tesla. Bullish investors may combat this ideology with the fact that earnings beat and margins expanded; however, it is noted in Tesla's 10-Q that these figures came in higher than expected partly due to one-off warranty and tariff benefits. Tesla's services and other figures are likely the highlight of the report, up 42% YoY. As Tesla continues to sell more vehicles, FSD sales, supercharging, maintenance, and insurance ...
There is a new class of up-and-coming businesses that are delivering multibagger gains month after month, and you don’t know many of them. TTM Technologies (NASDAQ:TTMI) is one of them, and it is up 600% in the past year. The stock has only been accelerating due to orders from multiple industries. TTM Technologies makes RF/microwave ... This Unknown Stock is Up 600%, Has a $1.6B Defense Backlog, a...
There is a new class of up-and-coming businesses that are delivering multibagger gains month after month, and you don’t know many of them. TTM Technologies (NASDAQ:TTMI) is one of them, and it is up 600% in the past year. The stock has only been accelerating due to orders from multiple industries. TTM Technologies makes RF/microwave ... This Unknown Stock is Up 600%, Has a $1.6B Defense Backlog, and You Don’t Know It
Dr. Michael Burry, the genius who made the movie-worthy bet against the housing market in the face of the Great Financial Crisis, has been quite active about his recent bets. The man shut down Scion Asset Management and is now free to voice his concerns and make big, bold bets on the short and long ... Michael Burry Bought Beaten‑Up Software Names. Here are the Two I’d Grab First
Dr. Michael Burry, the genius who made the movie-worthy bet against the housing market in the face of the Great Financial Crisis, has been quite active about his recent bets. The man shut down Scion Asset Management and is now free to voice his concerns and make big, bold bets on the short and long ... Michael Burry Bought Beaten‑Up Software Names. Here are the Two I’d Grab First
Sundry Photography Merck ( MRK ) is scheduled to report first-quarter earnings on April 30, during market hours, with analysts expecting a strong performance from Keytruda and Winrevair. The consensus EPS Estimate is -$1.47 , while revenue is expected to jump 2.3% to $15.85B. Over the last 3 months, EPS estimates have seen 3 upward revisions and 8 downward. Revenue estimates have seen 3 upward rev...
Sundry Photography Merck ( MRK ) is scheduled to report first-quarter earnings on April 30, during market hours, with analysts expecting a strong performance from Keytruda and Winrevair. The consensus EPS Estimate is -$1.47 , while revenue is expected to jump 2.3% to $15.85B. Over the last 3 months, EPS estimates have seen 3 upward revisions and 8 downward. Revenue estimates have seen 3 upward revisions and 4 downward. Seeking Alpha analyst ALLKA Research believes Merck’s defining moment will be sales of Keytruda Qlex, whose main role is to offset the launch of biosimilars to Keytruda from 2028. In Q4, Keytruda+Keytruda Qlex generated about $8.37 billion in revenue for it, up 6.8% year-on-year, the analyst noted. “One of the key catalysts I highlight for MRK is the potential FDA approval of Keytruda Qlex+Padcev on August 17 for the treatment of patients with MIBC who are cisplatin-eligible,” ALLKA Research said. However, it also highlighted a key risk from the U.S. launch of generic versions of Janumet in May , increasing competition in the type-2 diabetes and insomnia therapeutics market and Trump’s tariff threats, among others. Over the last 2 years, MRK has beaten EPS estimates 100% of the time and has beaten revenue estimates 88% of the time, leaving investors a little more optimistic ahead of the results. More on Merck Merck: Bullish Setup Into Q1 Earnings Merck: Aggressive M&A Efforts To Prepare For A Keytruda Patent Cliff Merck's Deal For Terns And Its Stellar CML Drug Candidate Looks Like Good Business Merck acquisition of Terns passes HSR waiting period expiration Merck inks AI deal worth up to $1B with Google Cloud